Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2008;118:1123-1129
Published online before print August 25, 2008, doi: 10.1161/CIRCULATIONAHA.107.738013
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
118/11/1123    most recent
CIRCULATIONAHA.107.738013v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gelzer, A. R.M.
Right arrow Articles by Gilmour, R. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gelzer, A. R.M.
Right arrow Articles by Gilmour, R. F., Jr
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*VERAPAMIL HYDROCHLORIDE
Related Collections
Right arrow Arrythmias-basic studies
Right arrowRelated Article

(Circulation. 2008;118:1123-1129.)
© 2008 American Heart Association, Inc.


Arrhythmia/Electrophysiology

Dynamic Mechanism for Initiation of Ventricular Fibrillation In Vivo

Anna R.M. Gelzer, DVM*; Marcus L. Koller, MD*; Niels F. Otani, PhD; Jeffrey J. Fox, PhD; Michael W. Enyeart, MS; Giles J. Hooker, PhD; Mark L. Riccio, MSEE; Carlo R. Bartoli, BS; Robert F. Gilmour, Jr, PhD

From the Departments of Clinical Sciences (A.R.M.G.) and Biomedical Sciences (N.F.O., M.W.E., M.L.R., C.R.B., R.F.G.), College of Veterinary Medicine, and Department of Statistical Science (G.J.H.), Cornell University, Ithaca, NY; Department of Cardiology, Center of Cardiovascular Medicine, Bad-Neustadt, Germany (M.L.K.); and Gene Network Sciences, Ithaca, NY (J.J.F.).

Correspondence to Anna Gelzer, College of Veterinary Medicine, Cornell University, Ithaca, NY 14853. E-mail arg9{at}cornell.edu

Received June 9, 2006; accepted July 11, 2008.

Background— Dynamically induced heterogeneities of repolarization may lead to wave-front destabilizations and initiation of ventricular fibrillation (VF). In a computer modeling study, we demonstrated that specific sequences of premature stimuli maximized dynamically induced spatial dispersion of refractoriness and predisposed the heart to the development of conduction block. The purpose of this study was to determine whether the computer model results pertained to the initiation of VF in dogs in vivo.

Methods and Results— Monophasic action potentials were recorded from right and left ventricular endocardium in anesthetized beagle dogs (n=11) in vivo. Restitution of action potential duration and conduction time and the effective refractory period after delivery of the basic stimulus (S1) and each of 3 premature stimuli (S2, S3, S4) were determined at baseline and during verapamil infusion. The effective refractory period data were used to determine the interstimulus intervals for a sequence of 4 premature stimuli (S2S3S4S5=CLVF) for which the computer model predicted maximal spatial dispersion of refractoriness. Delivery of CLVF was associated with discordant action potential duration alternans and induction of VF in all dogs. Verapamil decreased spatial dispersion of refractoriness by reducing action potential duration and conduction time restitution in a dose-dependent fashion, effects that were associated with reduced inducibility of VF with CLVF.

Conclusion— Maximizing dynamically induced spatial dispersion of repolarization appears to be an effective method for inducing VF. Reducing spatial dispersion of refractoriness by modulating restitution parameters can have an antifibrillatory effect in vivo.


 

CLINICAL PERSPECTIVE


Related Article:

Clinical Summaries
Circulation 2008 118: 1113-1114. [Extract] [Full Text]



This article has been cited by other articles:


Home page
Cardiovasc ResHome page
R. C. Ahrens-Nicklas, C. E. Clancy, and D. J. Christini
Re-evaluating the efficacy of {beta}-adrenergic agonists and antagonists in long QT-3 syndrome through computational modelling
Cardiovasc Res, June 1, 2009; 82(3): 439 - 447.
[Abstract] [Full Text] [PDF]